Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Erickson

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Human Pathology|February 16, 2018
New prostate cancer grade grouping system predicts survival after radical prostatectomyAndrew Erickson, Kevin Sandeman, Kanerva Lahdensuo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentAbderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
Oncotarget|August 23, 2018
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomyJohanna K Björk, Ilmari Ahonen, Tuomas Mirtti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2019
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerBassem R Haddad, Andrew Erickson, Vindhya Udhane, et al.
European Urology Oncology|April 23, 2021
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal DiseaseAndrew Erickson, Alicia Hayes, Timothy Rajakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomyKanerva Lahdensuo, Andrew Erickson, Irena Saarinen, et al.
Nature Communications|September 17, 2022
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clonesMaja Marklund, Niklas Schultz, Stefanie Friedrich, et al.
Plos One|July 10, 2020
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomyKevin Sandeman, Juho T Eineluoto, Joona Pohjonen, et al.
International Journal of Cancer|May 4, 2023
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancerTimo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, et al.
The Prostate|February 21, 2022
Multiplex immunohistochemical phenotyping of T cells in primary prostate cancerBusra Ozbek, Onur Ertunc, Andrew Erickson, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Human Pathology|February 16, 2018
New prostate cancer grade grouping system predicts survival after radical prostatectomyAndrew Erickson, Kevin Sandeman, Kanerva Lahdensuo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentAbderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka Lehto, et al.
Oncotarget|August 23, 2018
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomyJohanna K Björk, Ilmari Ahonen, Tuomas Mirtti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 12, 2019
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate CancerBassem R Haddad, Andrew Erickson, Vindhya Udhane, et al.
European Urology Oncology|April 23, 2021
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal DiseaseAndrew Erickson, Alicia Hayes, Timothy Rajakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 2016
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomyKanerva Lahdensuo, Andrew Erickson, Irena Saarinen, et al.
Nature Communications|September 17, 2022
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clonesMaja Marklund, Niklas Schultz, Stefanie Friedrich, et al.
Plos One|July 10, 2020
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomyKevin Sandeman, Juho T Eineluoto, Joona Pohjonen, et al.
International Journal of Cancer|May 4, 2023
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancerTimo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, et al.
The Prostate|February 21, 2022
Multiplex immunohistochemical phenotyping of T cells in primary prostate cancerBusra Ozbek, Onur Ertunc, Andrew Erickson, et al.
Pageof 3